Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: Connecticut ephedrine ban

This article was originally published in The Tan Sheet

Executive Summary

Connecticut ephedrine ban: State Department of Consumer Protection proposes rule to prohibit the sale of ephedrine in non-drug form. The rule would classify "products containing ephedrine, ephedrine alkaloids, or their isomers and analogs, and dietary supplements from which ephedrine, ephedrine alkaloids, or their isomers and analogs can be derived, including but not limited to ephedra, ephedra sinica, ma huang and epitonin" as a "banned hazardous substance." FDA-approved OTC drugs would be exempt. A hearing on the issue was held July 18. Other states such as Florida and Texas have taken similar actions. Ohio also initiated a ban but later reversed it...





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts